How long does it take for grade 4 glioblastoma to recur after surgery?

Glioblastoma (GBM) is the most common and most malignant primary brain tumor, which is highly aggressive and rapidly growing. Although treatments such as surgery, radiotherapy, and chemotherapy can slow the progression of the disease, the recurrence rate of GBM is extremely high. Most patients experience recurrence some time after treatment, especially within a few months to a year after surgical removal.

1.Time for recurrence after surgery

The time to recurrence of GBM varies depending on factors such as individual patient differences, tumor location, treatment regimen, and patient response. Generally speaking, the recurrence time after surgery is usually 6 months to 1 years, but some patients may have recurrence within 3 months after surgery. Recurrent tumors usually occur in the area surrounding the original tumor or in the area that remains after the original tumor has been removed. Even if the surgical removal is complete, residual tiny tumor cells may continue to grow and cause recurrence.

2.The time to recurrence depends on several factors:

Extent of surgical resection: Tumors that are completely removed may relapse more slowly, while patients with more residual tumor cells may relapse more quickly.

Treatment plan: For patients who receive postoperative radiotherapy and chemotherapy, if the tumor does not respond well to treatment, the time to recurrence will be shorter.

Molecular characteristics of tumors: For example, patients with MGMT gene mutations have better chemotherapy effects and may delay recurrence.

Patient’s physical condition: Younger and better-healthy patients take longer to relapse.

In general, despite various treatments, GBMrecurrence time is mostly within one year after surgery. The goal of treatment is mainly to delay recurrence and improve the patient's quality of life.

(Click to view an introduction to drugs for the treatment of glioblastoma.)

xa0

Reference materials

1.Stupp R, et al. "Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma." New England Journal of Medicine, 2005.

2.Weller M, et al. "Current concepts and management of glioblastoma." Annals of Neurology, 2015.

3.National Comprehensive Cancer Network (NCCN). Glioblastoma Treatment Guidelines.

https://www.nccn.org